Author: user

[ad_1] JPMorgan maintains Experian stock Overweight with GBP44.00 target [ad_2] Source link

[ad_1] BofA raises Snap stock price target to $14.50, maintains Neutral [ad_2] Source link

[ad_1] Premium Bonds savers have been warned they could be missing out on better returns if they switched to a savings account.Customers have a lower chance of bagging a prize in the monthly draw, with the odds of each £1 winning down from 21,000 to one to 22,000 to one.The prize fund rate for Premium Bonds has fallen twice in recent months, dropping from 4.4% to 4.1% in December, and then down to 4% in January.Amy Knight, personal finance expert at NerdWallet UK, spoke about the benefits of Premium Bonds and who they may suit as a savings option.She explained:…

[ad_1] Image source: Getty Images The DCC (LSE:DCC) share price is falling this morning (5 February) after an uninspiring update. But I hold the stock and it’s also at the top of my list of FTSE 100 shares to snap up imminently assuming the price stays low. The firm is looking to divest its Healthcare and Technology operations, leaving the Energy division behind. And for the time being, this is probably more important than the latest set of trading results.  No surprises According to DCC’s management, trading during the last three months of 2024 was broadly in line with the…

[ad_1] Apple shares fell on Wednesday after Bloomberg reported that Chinese regulators are considering whether to open a formal probe into the iPhone giant’s App Store fees and policies.Shares of Apple were down 2.66% at 09:34 a.m. London time in premarket trading.The State Administration for Market Regulation (SAMR) is looking into policies that include Apple taking a cut of as much as 30% on in-app spending, as well as blocking third-party payment services and app stores, Bloomberg reported Wednesday, citing people familiar with the matter.China’s market regulator has not decided whether to formally open an investigation into Apple, according to…

[ad_1] Image source: Getty images GSK (LSE:GSK) shares ended 2024 on a sour note after what proved to be a rollercoaster year. The pharma giant dropped 7% over the 12 months, as worries over Zantac litigation and potential shake-ups in US healthcare policy shook investor confidence. Yet the underlying health of the FTSE 100 firm has remained steadfast, as illustrated by impressive full-year results released today (5 February). GSK’s share price has spiked 5% following the news. Can it keep going? Forecasts beaten Helped by what it described as “accelerating momentum in Specialty Medicines“, full-year revenues at GSK rose 7%…

[ad_1] Image source: Getty Images With a fresh £20,000 Stocks and Shares ISA contribution limit at my disposal this April, I turned to ChatGPT to help me build the perfect FTSE 100 portfolio. I told the artificial intelligence (AI) chatbot I wanted to balance risk and reward with a mix of growth and income stocks across different sectors. While I’d never treat AI as a stock tipper, I was curious to hear its view. Its first pick is a share I bought last year (but sometimes wish I hadn’t): spirits giant Diageo. ChatGPT plucked this from the consumer good sector,…

[ad_1] Delta Air Lines SVP sells shares worth $447,284 [ad_2] Source link

[ad_1] Morgan Stanley lifts Richemont stock to Overweight, target to CHF200 [ad_2] Source link

[ad_1] Image source: Getty Images For a long time, I liked the look of drinks giant Diageo (LSE: DGE), but not the price. Then the Diageo share price fell to what I thought was an attractive level and I bought a stake, which I still own. Since then however, the share has continued to lose momentum. Business problems have mounted. Is this weakness a potential bargain for an investor with a long-term approach like me? Or should I avoid buying any more shares in the Guinness brewer? Latest results paint a mixed picture The company released its interim results Tuesday…